EUVIMEDEUVIMED entdecken
Open Access

Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals

Jagpreet Chhatwal, Ali Hajjar, Peter P Mueller, Gizem Nemutlu, Neeti Kulkarni, Mary Linton B Peters, Fasiha Kanwal

Clinical Gastroenterology and Hepatology · 2024-01 · 22 (1) · 91-101.e6

DOI: 10.1016/j.cgh.2023.05.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024-01. Verfasst von Jagpreet Chhatwal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Dana Farber/Harvard Cancer Center…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis C, Chronic, Hepatitis C. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis C, ChronicHepatitis CHumansIncidenceAntiviral AgentsLiver CirrhosisHepacivirus

Stichwörter der Autor:innen

Cost-effectiveness AnalysisLiver CancerPreventionScreening

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Dana Farber/Harvard Cancer Center, Boston, Massachusetts; Liver Center and Gastrointestinal Division, M…
  • Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Prince Mohammed Bin Salman College of Business & Entrepreneurship, King Abdullah Economic City, Saudi A…
  • Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Brandeis International Business School, Brandeis University, Boston, Massachusetts.
  • Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Department of Medicine, Baylor College of Medicine, Houston, Texas; Houston Veterans Affairs Health Services Research and Development Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Te…

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health
  • US Department of Defense
  • American Cancer Society
  • National Cancer Institute
  • Cancer Prevention and Research Institute of Texas

Zitieren

APA

Chhatwal, J., Hajjar, A., Mueller, P. P., Nemutlu, G., Kulkarni, N., Peters, M. L. B., & Kanwal, F. (2024). Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals. Clinical Gastroenterology and Hepatology, 22(1), 91-101.e6. https://doi.org/10.1016/j.cgh.2023.05.024

Vancouver

Chhatwal J, Hajjar A, Mueller PP, Nemutlu G, Kulkarni N, Peters MLB, et al. Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals. Clinical Gastroenterology and Hepatology. 2024;22(1):91-101.e6. doi:10.1016/j.cgh.2023.05.024

BibTeX
@article{Chhatwal2024,
  author = {Chhatwal, Jagpreet and Hajjar, Ali and Mueller, Peter P and Nemutlu, Gizem and Kulkarni, Neeti and Peters, Mary Linton B and Kanwal, Fasiha},
  title = {Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2024},
  volume = {22},
  number = {1},
  pages = {91--101.e6},
  doi = {10.1016/j.cgh.2023.05.024}
}
Kostenlos starten →